Evaluating Patients With Arthritis of Recent Onset
Studies in Pathogenesis and Prognosis
Hani S. El-Gabalawy, MD;
Paul Duray, MD;
Raphaela Goldbach-Mansky, MD
JAMA. 2000;284:2368-2373.
Inflammatory synovitis of recent onset poses a diagnostic and prognostic challenge to primary care physicians and rheumatologists. A lack of understanding of the underlying etiologic and pathogenic processes limits the ability to distinguish forms of arthritis that follow a benign, self-limiting course from forms that proceed to an aggressive, erosive disease requiring intensive immunosuppressive therapy. It is estimated that between 30% and 40% of patients presenting with early synovitis have disease that remains unclassified. Using data from a cohort of patients with early synovitis and reviewing current literature, we discuss investigational approaches toward a new classification of patients with early synovitis. Although a lack of understanding of this heterogeneous clinical syndrome has led clinicians to take a largely empirical approach to treatment thus far, the evolving awareness of disease predisposition at a genetic level and the expanding ability to specifically manipulate biological pathways may ultimately change the approach to this clinical problem.
Author Affiliations: National Institutes of Health, Bethesda, Md.
RELATED ARTICLE
November 8, 2000
JAMA. 2000;284(18):2393-2394.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis
Newkirk et al.
Rheumatology (Oxford) 2005;44:1433-1441.
ABSTRACT
| FULL TEXT
|
